4.3 Article

PedsQL Eosinophilic Esophagitis Module: Feasibility, Reliability, and Validity

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPG.0b013e31828f1fd2

Keywords

children; eosinophilic esophagitis; health-related quality of life; patient-reported outcomes; pediatrics; PedsQL

Funding

  1. Children's Digestive Health and Nutrition Foundation
  2. TAP, an AstraZeneca Eosinophilic Esophagitis Young Investigators Award
  3. Food Allergy Initiative
  4. Buckeye Foundation
  5. Campaign Urging Research for Eosinophilic Disorders Foundation
  6. Angels for Eosinophilic Research Foundation
  7. Public Health Service [P30 DK078392]
  8. NIH/NCRR Colorado CTSI [UL1 RR025780]
  9. Coordination for the Improvement of Higher Level Education Personnel (CAPES), Brazil
  10. Mapi Research Trust

Ask authors/readers for more resources

Objective:Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory condition with a paucity of information on health-related quality of life (HRQOL). The objective of the study was to report on the measurement properties of the PedsQL EoE Module.Methods:The PedsQL EoE Module was completed in a multisite study by 196 pediatric patients with EoE and 262 parents of patients with EoE.Results:The PedsQL EoE Module scales evidenced excellent feasibility (0.6%-3.1% missing), excellent group comparison reliability across total scale scores (patient 0.93; parent proxy 0.94), good reliability for the 7 individual scales (patient 0.75-0.87; parent proxy 0.81-0.92), excellent test-retest reliability (patient intraclass correlation coefficient 0.88; parent intraclass correlation coefficient 0.82), demonstrated no floor effects and low ceiling effects, and demonstrated a high percentage of scaling success for most scales. Intercorrelations with the PedsQL Generic Core Scales were in the medium (0.30) to large (0.50) range. PedsQL EoE Module scores were worse among patients with active histologic disease (5 eos/hpf) compared with those in remission (patient self-report: 63.3 vs 69.9 [P<0.05]; parent proxy report: 65.1 vs 72.3 [P<0.01]), and those treated with dietary restrictions compared with those with no restrictions (patient self-report: 61.6 vs 74.3 [P<0.01]; parent proxy report: 65.5 vs 74.7 [P<0.01]).Conclusions:The results demonstrate excellent measurement properties of the PedsQL EoE Module. Patients with active histologic disease and those treated with dietary restrictions demonstrated worse PedsQL scores. The PedsQL EoE Module may be used in the evaluation of pediatric EoE disease-specific HRQOL in clinical research and practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available